论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhou Q, Jiang H, Zhang J, Yu W, Zhou Z, Huang P, Wang J, Xiao Z
Received 6 August 2018
Accepted for publication 24 September 2018
Published 26 November 2018 Volume 2018:10 Pages 6339—6355
DOI https://doi.org/10.2147/CMAR.S182859
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 3
Editor who approved publication: Dr Xueqiong Zhu
Introduction: Uridine-cytidine
kinase 2 (Uck2) has been demonstrated to activate antitumor prodrugs and
regulate chemosensitivity in cancer cells. However, the expression and function
of Uck2 in hepatocellular carcinoma (HCC) remain unknown. In this study, we
were the first to systematically elucidate the role of Uck2 in HCC.
Patients and methods: Uck2 gene
expression was queried between normal liver tissues and HCC in a web-based data
mining platform (www.oncomine.org). Uck2 gene expression in
tissue microarray was determined by immunohistochemical staining. The clinical
and prognostic significance of Uck2 expression was statistically analyzed.
Stable cell lines with increased Uck2 expression were established using
lentivirus-based vectors, and RNAi technology was used to transiently
downregulate Uck2 expression. Cell migration and invasion were assessed by
using wound-healing and transwell assays, respectively. mRNA and protein
expression levels were determined using quantitative real-time PCR and Western
blotting, respectively.
Results: We report
the upregulation of Uck2 expression in HCC tissues. We explored the
relationship between Uck2 levels and the clinicopathological features of HCC
patients. High Uck2 notably correlated with early recurrence and poor prognosis
in HCC patients. Uck2 expression in HCC cell lines regulated the cell migration
and invasion capacities in vitro. The stable overexpression of Uck2 in Bel-7402
cells promoted their metastasis ability in vivo. Furthermore, the Uck2
upregulation increased the MMP2/9 expression and activated the Stat3 signaling
pathway. In addition, WP1066, a Stat3 inhibitor, neutralized the effects of
Uck2 on the MMP2/9 expression and the migration and invasion capacities of HCC
cells.
Conclusion: Our data
suggest that Uck2 promotes HCC cell migration and invasion via the Stat3
signaling pathway and might be a novel potential target in HCC therapy.
Keywords: uridine-cytidine
kinase 2, metastasis, hepatocellular carcinoma, oncogene, signal transducer,
activator of transcription 3
